Home
>
National Drug Code (NDC)
>
Carbidopa, Levodopa and Entacapone
Carbidopa, Levodopa and Entacapone - 47335-910-08 - (Carbidopa, Levodopa and Entacapone)
Drug Information of Carbidopa, Levodopa and Entacapone
| Product NDC: | 47335-910 |
| Proprietary Name: | Carbidopa, Levodopa and Entacapone |
| Non Proprietary Name: | Carbidopa, Levodopa and Entacapone |
| Active Ingredient(s): | 37.5; 200; 150 mg/1; mg/1; mg/1 & nbsp; Carbidopa, Levodopa and Entacapone |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Carbidopa, Levodopa and Entacapone
| Product NDC: | 47335-910 |
| Labeler Name: | Sun Pharma Global FZE |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA079085 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20120522 |
Package Information of Carbidopa, Levodopa and Entacapone
| Package NDC: | 47335-910-08 |
| Package Description: | 100 TABLET, FILM COATED in 1 BOTTLE (47335-910-08) |
NDC Information of Carbidopa, Levodopa and Entacapone
| NDC Code | 47335-910-08 |
| Proprietary Name | Carbidopa, Levodopa and Entacapone |
| Package Description | 100 TABLET, FILM COATED in 1 BOTTLE (47335-910-08) |
| Product NDC | 47335-910 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Carbidopa, Levodopa and Entacapone |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 20120522 |
| Marketing Category Name | ANDA |
| Labeler Name | Sun Pharma Global FZE |
| Substance Name | CARBIDOPA; ENTACAPONE; LEVODOPA |
| Strength Number | 37.5; 200; 150 |
| Strength Unit | mg/1; mg/1; mg/1 |
| Pharmaceutical Classes | Aromatic Amino Acid Decarboxylation Inhibitor [EPC],DOPA Decarboxylase Inhibitors [MoA],Aromatic Amino Acid Decarboxylation Inhibitor [EPC],DOPA Decarboxylase Inhibitors [MoA],Catechol O-Methyltransferase Inhibitors [MoA],Catechol-O-Methyltransferase Inhibitor [EPC] |
